• Modeling the cost-effectiveness of NVX-CoV2705 and the public health impact of vaccination for the prevention of seasonal COVID-19 in the US. 03.11.2026

• Post-ARDS Pulmonary Fibrosis:
  From Molecular Mechanisms to Clinical Management. 03.11.2026

• Timing of Long COVID Improvement in Prospectively Followed RECOVER-Adult Participants. 03.11.2026

• Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered spike localization and increased cell-to-cell transmission 03.11.2026

• Saccharomyces cerevisiae asosida SARS-CoV-2 S1 rekombinant oqsilini olish texnologiyasini o‘rganish 03.11.2026

• SARS-CoV-2 S1 oqsilini Saccharomyces cerevisiae hujayralarida rekombinant ekspressiya qilishni baholash 03.11.2026

• A Refined Search of SARS-CoV-2 Main Protease Inhibitors as COVID-19 Antivirals 03.11.2026

• ASSOCIATIONS BETWEEN SARS-COV-2 INFECTION, COVID-19 VACCINATION, AND AMYOTROPHIC LATERAL SCLEROSIS 03.11.2026

• Cryptic spread of SARS-CoV-2 undermined targeted travel restrictions 03.11.2026

• Retrospective and Bibliometric Assessment of SARS-CoV-2 Viral Culture (2020–2025):
  Navigating Five Years of Technological Shifts, Translational Research and Viral Immune Evasion 03.11.2026

• Polyaniline-based fluorescence nucleic acid biosensor for SARS-COV-2 RNA monitoring:
  from analytical validation to wastewater analysis 03.11.2026

• Therapeutic opportunities of marine-derived bioactive compounds against SARS-CoV-2 and other enveloped viruses 03.11.2026

• Multimodal LFIA Platform Integrating Visual Readout, Smartphone Grayscale Imaging and Surface-Enhanced Raman Scattering for Point-of-Care Detection of SARS-CoV-2 Protein 03.11.2026

• The Activation of NF-κB by the SARS-CoV-2 Spike Protein and Its Role in Epigenetic Age Acceleration, Inflammaging, and, Finally, Senescence 03.11.2026

• Non-covalent inhibitors targeting SARS-CoV-2 3CLpro:
  structural insights and developmental landscape 03.11.2026

• Dual-Format Plasmonic Biosensors for the Detection of SARS-CoV-2 and the Oxidative Stress Biomarker sNOX2-dp 03.11.2026

• Indiscriminate trans-cleavage activity of CRISPR/SuCas12a2 enables sensitive detection of SARS-CoV-2 03.11.2026

• Mathematical Analysis and Computer Simulations of a Generalized Model of Sars-CoV-2 Induced Covid- 19 Epidemiological Dynamics 03.11.2026

• Estimating viral interference from wastewater surveillance:
  a Bayesian multi-pathogen SEIR framework. 02.11.2026

• SARS-CoV-2 ORF7a induces cytotoxicity associated with AP-1 signaling and ferroptosis-related responses. 02.11.2026

• Non-invasive quantification of lower airway antigen-specific antibodies using exhaled breath particles - an observational proof-of-concept study. 02.11.2026

• Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland:
  An observational study. 02.11.2026

• SARS-CoV-2 mRNA Vaccination in Pregnancy and Child Neurodevelopment at 18 to 30 Months. 02.11.2026

• Risk Factors for COVID-19 and Influenza Nonvaccination during the 2025-2026 Respiratory Season among a Cross-Sectional Sample of Older US Adults. 02.11.2026

• Sensitive electrochemical competitive detection of SARS-CoV-2 antigen on a 2D MoWSe(2) bioelectrode:
  a new screening strategy for water contamination and clinical diagnostics. 02.11.2026

• Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3. 02.11.2026

• Diagnostic performance of antigen-based rapid test kits for six respiratory viruses in children:
  comparison with a multiplex PCR panel and correlation with viral load. 02.11.2026

• Cerebellar and frontal lobe alterations in pulmonary hypertension implicate an inflammatory lung vascular/brain axis. 02.11.2026

• Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3. 02.11.2026

• SARS-CoV-2 mRNA Vaccination in Pregnancy and Child Neurodevelopment at 18 to 30 Months. 02.11.2026

• Symptom Burden, Autoantibodies and T Cell Reactivity After SARS-CoV-2 Infection:
  Findings from the McPoC Study 02.11.2026

• Longitudinal monitoring of Cu and Zn isotopes in serum of ICU patients with SARS-Cov-2 infection 02.11.2026

• Factors Associated with Depressive Symptoms Approximately One-Year After SARS-CoV-2 Infection 02.11.2026

• Microvesicular steatosis of the liver in Wistar rats immunized with the SARS-CoV-2 S protein 02.11.2026

• Experimental model of multi-organ autoimmunity induced by SARS-CoV-2 S protein 02.11.2026

• SARS-CoV-2 ORF7a induces cytotoxicity associated with AP-1 signaling and ferroptosis-related responses 02.11.2026

• Molecular Therapeutic Development Against SARS-CoV-2:
  Structural Insights and Comparative Cellular Antiviral Evaluation with Established Antivirals 02.11.2026

• Factors Associated with SARS-CoV-2 and Influenza A Positivity and In-Hospital Mortality Among Hospitalized Patients with Suspected Acute Respiratory Infection:
  A Retrospective Cohort Study 02.11.2026

• Association of Innate Immune Responses with SARS-CoV-2 Positivity in Children Under Five Years Old 02.11.2026

• Figure S1 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Data from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S3 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S4 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S6 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S2 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S5 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• STROBE checklist 1 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Supplementary Tables S1-S2 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Palladium(II) aminoadamantane complexes:
  a promising approach to impair SARS-CoV-2 infection 02.11.2026

• Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people 02.11.2026

• Reported rhythm and conduction abnormalities in children and adolescents with SARS-CoV-2 infection:
  a systematic review and meta-analysis 02.11.2026

• Crystallographic fragment screening in cancer and antiviral drug discovery:
  from electron density to translational outcomes. 01.11.2026

• Correction:
  SARS‑CoV‑2 envelope protein triggers depression‑like behaviors and dysosmia via TLR2‑mediated neuroinflammation in mice. 01.11.2026

• Is SARS-CoV-2 Infection (COVID-19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS-CoV-2 Infection in Wales. 01.11.2026

• Independent Evaluation of Four SARS-CoV-2 Antigen Rapid Tests Against qRT-PCR in Niger 01.11.2026

• Creutzfeldt-Jakob disease following SARS-CoV-2 infection with rapid neurological decline:
  a case report 01.11.2026

• HEMATOLOGICAL AND RENAL BIOMARKERS IN CRITICALLY ILL PATIENTS WITH COVID-19 IN A BRAZILIAN ICU:
  A RETROSPECTIVE COHORT STUDY. 31.10.2026

• Identifying phase separation modulators mediated by the SARS-CoV-2 nucleocapsid protein using a structure-based drug discovery approach. 31.10.2026

• The Impact of Socioeconomic and Geographic Factors in Respiratory Virus Testing in Australia. 31.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection 31.10.2026

• Recommendations for enhancing COVID-19 test and treat programmes in four African countries:
  insights and strategies from a qualitative study. 29.10.2026

• SARS-CoV-2 membrane (M) protein activates TLR4 to induce an inflammatory response. 29.10.2026

• Simultaneous detection of influenza and SARS-CoV-2 on an AI-nanopore multiplex platform. 27.10.2026

• SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. 26.10.2026

• Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. 26.10.2026

• First evidence of an association between alexithymia and reduced humoral immunity following COVID-19 vaccination, independent of insomnia and metabolic factors in healthcare workers. 23.10.2026

• Fangchinoline as a Dual-action Therapeutic Agent:
  Recent Advances in Cancer and Infectious Disease Research. 21.10.2026

• The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication. 21.10.2026

• Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026

• Inflammatory and immunologic analysis of bronchoalveolar lavage from patients with post-COVID-19 lung disease. 19.10.2026

• Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature. 19.10.2026

• The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026

• Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection. 16.10.2026

• Iron Status in Patients with SARS-CoV-2 Infection. 15.10.2026

• Scaling of SARS-CoV-2 Genomic Divergence with Cumulative COVID-19 Infections. 15.10.2026

• SARS-CoV-2 nucleocapsid protein hijacks host transcription by targeting eEF1A1. 14.10.2026

• SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026

• Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026

• Social inequalities in SARS-CoV-2 infection in France:
  An intersectional analysis 01.10.2026

• Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes:
  Quanta Profiles and Infection Control. 01.10.2026

• Divergent systemic and airway mucosal adaptive immunity to SARS-CoV-2 in African adults 29.09.2026

• The other immune landscape of SARS-CoV-2 evolution. 28.09.2026

• Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026

• Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026

• Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026

• Gut microbial allies and adversaries in SARS-CoV-2 infection. 10.09.2026

• Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies 07.09.2026

• A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026

• Antibody-mediated SARS-CoV-2 entry and conformational regulation. 21.08.2026

• Ingavirin as a potentially effective treatment for coronavirus:
  An investigative study of patient outcomes. 18.08.2026

• Etiology and co-infection patterns of acute respiratory viral infections in Bhopal, India:
  insights from short-term molecular study. 11.08.2026

• Loneliness, social support and stress among Black pregnant women during the COVID-19 pandemic:
  a mixed methods approach. 06.08.2026

• Effect of pirfenidone on the short- and long-term outcomes in pulmonary infection-related acute respiratory distress syndrome:
  a prospective cohort study. 05.08.2026

• SARS-COv-2, influenza and other respiratory virus co-circulation during an outbreak in a rural health zone in Democratic Republic of Congo, 2024-2025. 05.08.2026

• The diagnostic role of SARS-CoV-2 in routine respiratory testing after policy adjustment:
  a real-world laboratory study integrating longitudinal PCR and respiratory pathogen testing workflow data. 05.08.2026

• Associations between individual-level factors and adherence to social distancing measures during the COVID-19 pandemic:
  a global meta-analysis. 05.08.2026

• The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026

• Advances on Sensors and Diagnostics of SARS-CoV-2 Biomarkers. 01.08.2026

• Prevalence of SARS-COV-2 infection, Relationship between SARS-CoV-2 and HIV among Sex Workers in Cotonou. 01.08.2026

Quellen: PubMed, Europe PMC & CrossRef